IRIS - Res&Arch Institutional Research Information System - Research & Archive

RUGGERI, Loredana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.356
EU - Europa 2.532
AS - Asia 2.315
SA - Sud America 367
AF - Africa 66
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.287
SG - Singapore 1.087
IE - Irlanda 434
IT - Italia 401
CN - Cina 363
UA - Ucraina 318
RU - Federazione Russa 310
HK - Hong Kong 295
SE - Svezia 288
BR - Brasile 282
VN - Vietnam 214
DE - Germania 184
FI - Finlandia 182
FR - Francia 155
GB - Regno Unito 95
KR - Corea 74
IN - India 59
BD - Bangladesh 37
AR - Argentina 35
CA - Canada 34
TR - Turchia 26
IQ - Iraq 25
NL - Olanda 24
PL - Polonia 24
MX - Messico 21
ZA - Sudafrica 21
BE - Belgio 18
UZ - Uzbekistan 17
AT - Austria 16
ID - Indonesia 15
PK - Pakistan 15
RO - Romania 14
CH - Svizzera 13
ES - Italia 13
JP - Giappone 13
PH - Filippine 13
SA - Arabia Saudita 13
CO - Colombia 12
VE - Venezuela 11
CZ - Repubblica Ceca 10
GR - Grecia 9
EC - Ecuador 8
JO - Giordania 8
LB - Libano 8
KE - Kenya 7
LT - Lituania 7
OM - Oman 7
TN - Tunisia 7
BO - Bolivia 6
EG - Egitto 6
MA - Marocco 6
MY - Malesia 6
PY - Paraguay 6
DZ - Algeria 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
KZ - Kazakistan 2
LV - Lettonia 2
ML - Mali 2
MU - Mauritius 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
TW - Taiwan 2
UG - Uganda 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GF - Guiana Francese 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KI - Kiribati 1
LC - Santa Lucia 1
MD - Moldavia 1
MN - Mongolia 1
NA - Namibia 1
NR - Nauru 1
PA - Panama 1
QA - Qatar 1
Totale 8.636
Salva come PNG Salva come JPEG
Città #
Singapore 805
Chandler 443
Dublin 434
San Jose 302
Hong Kong 294
San Mateo 287
Ashburn 241
Boardman 156
Jacksonville 150
Perugia 149
Santa Clara 112
Moscow 108
Beijing 102
Medford 82
Princeton 82
Lauterbourg 81
Munich 74
Altamura 71
Ann Arbor 70
Seoul 69
Wilmington 65
Andover 63
Dong Ket 59
Helsinki 55
Lawrence 55
Ho Chi Minh City 51
The Dalles 50
Los Angeles 48
New York 48
Turku 37
Hanoi 32
Piscataway 32
Des Moines 30
Frankfurt am Main 27
São Paulo 27
Saint Petersburg 24
Norwalk 21
Woodbridge 21
Orem 20
Brooklyn 18
Redwood City 17
Houston 16
Rome 16
Atlanta 15
London 15
Shanghai 15
Amsterdam 14
Brussels 14
Dallas 14
Johannesburg 14
Rio de Janeiro 14
Warsaw 14
Chicago 13
Espoo 13
Foligno 13
Montreal 13
San Paolo di Civitate 13
Tokyo 13
Baghdad 12
Boston 12
Denver 12
Falkenstein 12
Stockholm 12
Tashkent 12
Chennai 11
San Francisco 11
Guangzhou 10
Izmir 10
Milan 10
Brasília 9
Hefei 9
Bucharest 8
Da Nang 8
Redmond 8
Bologna 7
Lahore 7
Phoenix 7
Quito 7
San Diego 7
Seattle 7
Barnet 6
Belo Horizonte 6
Brno 6
Dhaka 6
Florence 6
Manchester 6
Mexico City 6
Mumbai 6
Nairobi 6
Oklahoma City 6
Philadelphia 6
Riyadh 6
Toronto 6
Vienna 6
Amman 5
Ancona 5
Auburn Hills 5
Campinas 5
Caracas 5
Changsha 5
Totale 5.473
Salva come PNG Salva come JPEG
Nome #
Innate immunity against hematological malignancies 163
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 156
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 147
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 144
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 141
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 133
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 130
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 130
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 125
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 125
"Designed" grafts for HLA-haploidentical stem cell transplantation. 124
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 124
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 122
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 121
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 121
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 120
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 120
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 120
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 119
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 117
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 116
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 115
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 114
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 111
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 109
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 106
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 105
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 105
Natural killer cell alloreactivity for leukemia therapy. 101
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 98
Preclinical characterization of 1-7F9,a novel human anti-KIR receptor therapeutic antibody that augments natural kille-mediated killing of tumor cells. 98
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 98
Alloreactive natural killer cells for the treatment of acute myeloid leukemia: From stem cell transplantation to adoptive immunotherapy 98
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 97
Cellular therapy: exploiting NK cell alloreactivity in transplantation 96
NCRs and DNAM-1 mediate NK cell recognition and iysis of human and mouse melanoma cell lines in vitro and in vivo 96
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 96
Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation 95
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 94
Natural killer cells: biology and application in stem-cell transplantation 94
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 94
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 92
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation 92
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 92
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 92
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 91
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 91
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells. 90
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. 90
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. 89
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants 89
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 89
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 88
New mechanism of lymphoma-induced bone marrow aplasia 88
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. 87
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 87
Treatment of high-risk acute leukemia with T-cell-depleted stem cell related donors with one fully mismatched HLA haplotype. 87
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 86
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 85
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation 85
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 85
Identifying NK alloreactive donors for haploidentical hematopoietic stem cell transplantation 85
Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. 84
Haploidentical transplantation and natural killer cell recognition of missing self. 83
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants 83
Post-grafting granulocyte colony-stimulating factor administration impairs functional immune recovery in recipients of HLA haplotype-mismatched hematopoietic transplants 82
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 81
Transplantation for high-risk acute leukemia with high doses of T cell-depleted hematopoietic stem cells from haploidentical “three loci” incompatible donors. 75
Natural Killer (NK)-Cell Function and Anti-Leukemic Activity of a Large Population of CD3+/CD8+ T Cells Expressing NK Receptors for MHC Class I after “Three-Loci” HLA-Incompatible Bone Marrow Transplantation 74
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 74
Natural killer cells as a therapeutic tool in mismatched transplantation 74
Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. 74
Jack of all trades: thymosin α1 and its pleiotropy. 73
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. 72
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells 71
The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. 70
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect 68
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells 68
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 67
Next generation HLA-haploidentical HSCT 67
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 67
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 67
NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. 66
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 64
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 62
NK cells: a lesson from mismatched hematopoietic transplantation 62
Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation 61
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 61
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 60
Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant. 53
Natural killer cell-mediated lysis of autologous cells modified by gene therapy 52
Natural killer cell activity and killer immunoglobulin-like receptors in hematopoietic stem cell transplantation 51
null 46
null 36
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 34
null 27
EXTRAMEDULLARY INVOLVEMENT IN PATIENT-DERIVED XENOGRAFT MODELS OF ACUTE MYELOID LEUKEMIA (AML) WITH NUCLEOPHOSMIN (NPM-1) MUTATION 16
null 11
A specific stem cell program and CD112 immunological axis dysfunctions underpinning monosomy 7-associated myeloid neoplasms 10
Totale 8.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.900
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022873 14 235 29 51 45 5 6 231 10 36 101 110
2022/20231.394 91 258 15 108 97 150 4 67 524 8 53 19
2023/2024652 40 78 24 8 3 9 173 14 61 21 112 109
2024/20251.380 23 136 34 89 199 60 51 119 235 71 216 147
2025/20263.042 210 202 173 331 436 293 510 146 349 286 66 40
2026/202741 41 0 0 0 0 0 0 0 0 0 0 0
Totale 8.844